Topics

Sartorius supports first coronavirus vaccine in clinical trials

10:44 EDT 25 Mar 2020 | Manufacturing Chemist

CanSinoBIO and the Institute of Bioengineering in China have used Sartorius’ BIOSTAT STR single-use bioreactor system for the upstream preparation of the recombinant vaccine

Original Article: Sartorius supports first coronavirus vaccine in clinical trials

NEXT ARTICLE

More From BioPortfolio on "Sartorius supports first coronavirus vaccine in clinical trials"

Quick Search

Relevant Topics

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...